Hope S. Rugo, Sara M. Tolaney, Nancy Chan, Erika P. Hamilton, Marina Nasrin Sharifi, Kristine Rinn, Wassim Mchayleh, Rinat Yerushalmi, Neelima Vidula, Joyce O'Shaughnessy, Giuseppe Curigliano, Javier Cortés, Paula Muñoz Romero, Denise M. Lepley, Kathy Puyana Theall, Tomer Wasserman, Virginia G. Kaklamani. "Elacestrant (Ela) combinations with ribociclib (Ribo) and everolimus (Eve) in patients (pts) with ER+/HER2- locally advanced or metastatic breast cancer (mBC): Update from ELEVATE, a phase (Ph) 1b/2, open-label, umbrella study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1070